Individualized prediction of survival benefits from perioperative chemoradiotherapy for patients with resectable gastric cancer
Sign Up to like & getrecommendations! Published in 2020 at "Cancer Medicine"
DOI: 10.1002/cam4.3350
Abstract: The survival benefits of perioperative chemoradiotherapy (PCRT) and perioperative chemotherapy (PCT) for resectable gastric cancer (GC) patients remain unclear. This study aimed to compare the effects of PCRT and PCT in patients with resectable GC… read more here.
Keywords: gastric cancer; resectable gastric; survival benefits; cancer ... See more keywords